Champions Oncology公布了2024财年第二季度财报,财务状况显著改善,超出盈利预期,推动股价在盘后交易中大幅上涨。公司报告每股收益 (EPS)为0.05美元,远超预期亏损0.03美元。营收达到1350万美元,略高于预期的1332万美元。受此影响,该股在盘后交易中上涨10.15%,反映出投资者的乐观情绪。
L'Atalanta senza paura al test della verità contro il Real Madrid di Ancelotti: partita più aperta che mai. Inzaghi vede avvicinarsi gli ottavi di Champions ma il Bayer venderà cara la pelle ...
Champions Oncology(CSBR)发布Q2财报,2025财年前六月累计收入2755.00万美元,去年同期累计收入为2413.40万美元,同比增长14.15%。 2025财年前六月累计净利润204.10万美元,去年同期累计净亏损为463.70万美元。 本财年累计基本每股收益为0.15美元,去年同期为-0.34美元。 公司所属行业为制药。 Champions Oncology, Inc.
Full Replay from Session 1 on Day 1 of the 2024 WTT Champions event in Frankfurt, as the Singles Round of 32 gets underway. 播放 Women And Men, Round 32, Day 1, Session 1 ...
All the action from the 2024 edition of the World Table Tennis Champions tournament in Frankfurt, Germany. Full Replay from Day 8 of the 2024 WTT Champions event in Frankfurt, as the Singles ...